Now that Eli Lilly has moved to claims-level 340B submissions, QuicksortRx gives you the tools to quantify risks and respond quickly to protect your 340B savings.
Request your personalized analysis.
On January 15, Eli Lilly announced that all covered entities must submit claims-level data to maintain their 340B pricing effective February 1. While this deadline has been postponed, health systems must be ready to quickly ensure compliance and avoid severe financial losses in the future.
Why It Matters:
How QuicksortRx Helps:
QuicksortRx is constantly evolving to help you stay ahead of the latest 340B policy and regulatory changes. Our team is here to guide you through today's challenges while developing new tools that power your future workflows.